Association of Implantable Cardioverter Defibrillators With Survival in Patients With and Without Improved Ejection Fraction
نویسندگان
چکیده
منابع مشابه
Association between prophylactic implantable cardioverter-defibrillators and survival in patients with left ventricular ejection fraction between 30% and 35%.
IMPORTANCE Clinical trials of prophylactic implantable cardioverter-defibrillators (ICDs) have included a minority of patients with a left ventricular ejection fraction (LVEF) between 30% and 35%. Because a large number of ICDs in the United States are implanted in such patients, it is important to study survival associated with this therapy. OBJECTIVE To characterize patients with LVEF betwe...
متن کاملdepression and associated factors in patients with implantable cardioverter-defibrillators
background: psychological problems such as depression constitute a dilemma that patients with the implantable cardioverter-defibrillator (icd) usually encounter and may impact their quality of life. the purpose of this study was to evaluate the prevalence of depression among adults with the icd and the relationship between depression and associated factors. methods: totally, 115 individuals ...
متن کاملthe past hospitalization and its association with suicide attempts and ideation in patients with mdd and comparison with bmd (depressed type) group
چکیده ندارد.
Survival in Patients With Automatic Implantable Cardioverter-Defibrillators
Background. Two hundred eighteen patients were evaluated in a two-phase approach (time to first appropriate discharge, survival after discharge) to identify factors that may be related to maximal benefit derived from use of an automatic implantable cardioverter-defibrillator (AICD). Methods and Results. One hundred ninety-seven patients survived implantation ofAICD, with or without concomitant ...
متن کاملImplantable cardioverter defibrillator outcome: beyond ejection fraction?
Over three decades of clinical experience have brought evidence that implantable cardioverter defibrillators (ICDs) should be considered as ‘gold standard’ therapy in prevention of sudden cardiac death. Implantable cardioverter defibrillators are currently indicated for secondary prevention in patients after cardiac arrest and life-threatening ventricular tachyarrhythmias or for primary prevent...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JAMA Cardiology
سال: 2017
ISSN: 2380-6583
DOI: 10.1001/jamacardio.2017.1413